These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 9425424)
1. Orbital tumour as a presenting symptom of breast carcinoma: value of detecting hormone receptors. Sekundo W; Vogel J Eye (Lond); 1997; 11 ( Pt 4)():560-3. PubMed ID: 9425424 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of steroid hormone receptors with respect to tumor cellularity. Geppert M; Smyczek-Gargya B; Dietl J; Schneider H Zentralbl Pathol; 1993 Aug; 139(3):217-9. PubMed ID: 8218122 [TBL] [Abstract][Full Text] [Related]
3. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status]. Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005 [TBL] [Abstract][Full Text] [Related]
5. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer. Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM; J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968 [TBL] [Abstract][Full Text] [Related]
6. Distinctive biology of pleomorphic lobular carcinoma of the breast. Moe RE; Anderson BO J Surg Oncol; 2005 May; 90(2):47-50. PubMed ID: 15844193 [No Abstract] [Full Text] [Related]
7. Bilateral orbital metastases from breast carcinoma. A case of false pseudotumor. Toller KK; Gigantelli JW; Spalding MJ Ophthalmology; 1998 Oct; 105(10):1897-901. PubMed ID: 9787361 [TBL] [Abstract][Full Text] [Related]
8. Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast. Boland GP; McKeown A; Chan KC; Prasad R; Knox WF; Bundred NJ Br J Cancer; 2003 Jul; 89(2):277-83. PubMed ID: 12865917 [TBL] [Abstract][Full Text] [Related]
9. Orbital metastasis due to interval lobular carcinoma of the breast: a potential mimic of lymphoma. Wolstencroft SJ; Hodder SC; Askill CF; Sugar AW; Jones EW; Griffiths AP Arch Ophthalmol; 1999 Oct; 117(10):1419-21. PubMed ID: 10532456 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women. Rao AV; Mohammed WA; Ragoonanan C; Omo-Igbinomwanhia NE West Indian Med J; 2002 Mar; 51(1):4-9. PubMed ID: 12089875 [TBL] [Abstract][Full Text] [Related]
11. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark. Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT; J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042 [TBL] [Abstract][Full Text] [Related]
12. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391 [TBL] [Abstract][Full Text] [Related]
13. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast]. Calzada L; Salazar EL; Pedron Nuevo N Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191 [TBL] [Abstract][Full Text] [Related]
14. Breast carcinoma in women 35 years and younger: a pathological study. Fernandopulle SM; Cher-Siangang P; Tan PH Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742 [TBL] [Abstract][Full Text] [Related]
15. Primary breast carcinoma: immunocytochemical and immunohistochemical evaluation of biological parameters. Sianesi M; Bozzetti C; Del Rio P; Nizzoli R; Cascinu S Chir Ital; 2000; 52(6):643-5. PubMed ID: 11199998 [TBL] [Abstract][Full Text] [Related]
16. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788 [TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046 [TBL] [Abstract][Full Text] [Related]
18. Progesterone binding cyst protein in hormone receptor positive breast cancer; a predictive factor for effect of adjuvant tamoxifen treatment. Søreide JA; Kolnes J; Skarstein A; Aas T; Kvinnsland S Anticancer Res; 1994; 14(5B):2105-8. PubMed ID: 7840507 [TBL] [Abstract][Full Text] [Related]
19. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women]. Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090 [No Abstract] [Full Text] [Related]
20. Effect of neoadjuvant chemotherapy on Ki67 labelling index, c-erbB-2 expression and steroid hormone receptor status in human breast tumours. Bottini A; Berruti A; Bersiga A; Brunelli A; Brizzi MP; Marco BD; Cirillo F; Bolsi G; Bertoli G; Alquati P; Dogliotti L Anticancer Res; 1996; 16(5B):3105-10. PubMed ID: 8920776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]